Various studies have investigated the ability of ChatGPT (OpenAI) to provide medication information; however, a new promising feature has now been added, which allows visual input and is yet to be evaluated. Here, we aimed to qualitatively assess its ability to visually recognize medications, through medication picture input, and provide patient education via written and visual output. The responses were evaluated by accuracy, precision and clarity using a 4-point Likert-like scale. In regards to handling visual input and providing written responses, GPT-4o was able to recognize all 20 tested medications from packaging pictures, even with blurring, retrieve their active ingredients, identify formulations and dosage forms and provide detailed, yet concise enough, patient education in an almost completely accurate, precise and clear manner with a score of 3.55 ± 0.605 (85%). In contrast, the visual output through GPT-4o generated images illustrating usage instructions contained many errors that would either hinder the effectiveness of the medication or cause direct harm to the patient with a poor score of 1.5 ± 0.577 (16.7%). In conclusion, GPT-4o is capable of identifying medications from pictures and exhibits contrasting patient education performance between written and visual output with very impressive and poor scores, respectively.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11538418PMC
http://dx.doi.org/10.1038/s41598-024-78577-yDOI Listing

Publication Analysis

Top Keywords

patient education
16
visual output
12
visually recognize
8
recognize medications
8
provide patient
8
visual input
8
written visual
8
patient
5
visual
5
assessing ability
4

Similar Publications

Interventions to improve patient health education competence among nursing personnel: A scoping review.

Nurse Educ Pract

January 2025

Xiangya School of Nursing, Central South University, 172 Tongzipo Road, Changsha, Hunan 410013, China; Xiangya Research Center of Evidence-based Healthcare, Central South University, 172 Tongzipo Road, Changsha, Hunan, 410013, China.; Xiangya Center for Evidence-Based Nursing Practice & Healthcare Innovation: A JBI Centre of Excellence, 172 Tongzipo Road, Changsha, Hunan 410013, China. Electronic address:

Aim: To determine what intervention strategies have been used in interventions aimed at improving the patient health education competence of nursing personnel.

Background: There is a growing body of research on educational interventions for improving nursing personnel's patient health education competence, but there are significant differences in the teaching objectives, content and methods of these studies, as well as a lack of standardized educational strategies.

Design: The scoping review was based on the Joanna Briggs Institute methodology.

View Article and Find Full Text PDF

Objective: We aimed to evaluate the content and quality of websites for consumers providing information about human papillomavirus (HPV) risks in patients with systemic lupus erythematosus (SLE).

Methods: We conducted an environmental scan of websites for patients and the general public with information about HPV and SLE. We searched Google from inception to June 2023, using the terms "HPV" and "lupus".

View Article and Find Full Text PDF

In a recent article, Haining outline several ethical and regulatory considerations for polygenic risk scores (PRSs), which may expand current embryonic screening to include polygenic diseases and non-disease traits. I argue in this response that the authors overlook a few crucial issues that nations should address. For adult-onset diseases, regulations must not only account for predictive accuracy of PRSs but also establish the precise circumstances that warrant testing-such as a disease's severity and the average age at which symptoms manifest.

View Article and Find Full Text PDF

Background: Patients are increasingly turning to the internet, and recently artificial intelligence engines (e.g., ChatGPT), for answers to common medical questions.

View Article and Find Full Text PDF

Biosimilars in pediatric rheumatology: innovations, challenges, and opportunities.

Expert Opin Biol Ther

January 2025

Department of Pediatric Rheumatology, Kocaeli University, Kocaeli, Turkey.

Article Synopsis
  • Biosimilars are biologic drugs that mimic established medications for treating rheumatic diseases and become available as cost-effective alternatives once original patents expire.
  • Since their introduction in pediatric rheumatology in 2013, several biosimilars have been launched, offering more treatment options for children with conditions like juvenile idiopathic arthritis.
  • The article emphasizes the need for education and effective communication among healthcare providers and patients to enhance understanding and ensure proper use of biosimilars.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!